Category: New products
-
Foundation Backing Expanded Pandemic Surveillance
A population genomics company is receiving foundation support for expanding its detailed surveillance of respiratory disease outbreaks in the U.S.
-
Trial Shows Results for Depression Drug with Therapy
Findings from a clinical trial show an experimental drug helps people in therapy for major depression reduce their symptoms compared to a placebo.
-
Engineered Chickpea with Increased Protein Unveiled
An agricultural biotechnology company is introducing genetically altered chickpeas with much higher protein content than today’s varieties.
-
Small Biz Grant Funds Biofilm Infection Peptides
A start-up company is receiving a National Institutes of Health grant to develop peptides for preventing bacterial films causing middle ear infections.
-
Saliva Test IDs Early Oral Cancer Signature
An analysis is shown to identify characteristic patterns found in microbial communities in saliva indicating early stages of oral and throat cancer.
-
Preclinical Test Advances Synthetic Bio ALS Treatment
A candidate treatment for amyotrophic lateral sclerosis or ALS made with synthetic genetic material is shown to improve motor function and survival in lab mice.
-
Oral Covid-19 Vaccine Trial Underway
An early-stage clinical trial is underway in South Africa testing the safety of a vaccine in capsule form to prevent Covid-19 disease.
-
CEPI Funds Multi-Variant Covid-19 Vaccine
Coalition for Epidemic Preparedness Innovations or CEPI is funding a new vaccine to protect against emerging Covid-19 variants and other coronaviruses.
-
Engineered Virus Delivers Brain-Targeted Gene Therapy
Neuroscience researchers designed a process for delivering gene therapies through the blood stream, but targeting only brain cells of lab animals.
-
NIH Opens $1M Maternal Health Diagnostics Challenge
National Institutes of Health began a competition for low-cost diagnostic technologies to improve maternal health, particularly in low-resource regions.